Ikarian Capital’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-282,159
Closed -$6.57M 168
2024
Q4
$6.57M Sell
282,159
-20,088
-7% -$468K 0.89% 17
2024
Q3
$8.89M Buy
+302,247
New +$8.89M 1.24% 11